Literature DB >> 12242045

Intracellular targeting of the type-I alpha regulatory subunit of cAMP-dependent protein kinase.

Sébastien Barradeau1, Tereza Imaizumi-Scherrer, Mary C Weiss, Daniela M Faust.   

Abstract

The specificity of cyclic adenosine monophosphate (cAMP)-mediated signaling events is achieved by the composition and biochemical properties of the different cAMP-dependent protein kinase holoenzymes (PKAI and II) and by compartmentalization of PKA to discrete subcellular locations. Intracellular localization is mediated by interaction with A-kinase anchoring proteins (AKAPs) that recruit PKAII close to its substrates and to sites where it can respond optimally to local changes in intracellular cAMP concentration, thereby directing and amplifying the effects of cAMP. This review presents recent evidence that indicates that specific AKAPs mediate PKAI anchoring through interaction with its regulatory subunit RI alpha, notably at the neuromuscular junction of skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242045     DOI: 10.1016/s1050-1738(02)00167-6

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  7 in total

1.  Suppressor of cytokine signaling-3 is a glucagon-inducible inhibitor of PKA activity and gluconeogenic gene expression in hepatocytes.

Authors:  Allison M Gaudy; Alicia H Clementi; Jean S Campbell; Alan V Smrcka; Robert A Mooney
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

2.  Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors.

Authors:  Elise Meoli; Ioannis Bossis; Laure Cazabat; Manos Mavrakis; Anelia Horvath; Sotiris Stergiopoulos; Miriam L Shiferaw; Glawdys Fumey; Karine Perlemoine; Michael Muchow; Audrey Robinson-White; Frank Weinberg; Maria Nesterova; Yianna Patronas; Lionel Groussin; Jérôme Bertherat; Constantine A Stratakis
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

3.  Regulation of intracellular cyclic AMP in skeletal muscle cells involves the efflux of cyclic nucleotide to the extracellular compartment.

Authors:  Rosely Oliveira Godinho; Valter Luiz Costa
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

4.  Phenotypic and transcriptomic analyses of Plasmodium falciparum protein kinase A catalytic subunit inhibition.

Authors:  Nathalie Wurtz; Jérôme Desplans; Daniel Parzy
Journal:  Parasitol Res       Date:  2009-09-25       Impact factor: 2.289

5.  The protein kinase A regulatory subunit R1A (Prkar1a) plays critical roles in peripheral nerve development.

Authors:  Li Guo; Audrey A Lee; Tilat A Rizvi; Nancy Ratner; Lawrence S Kirschner
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

Review 6.  Alterations of cAMP-dependent signaling in dystrophic skeletal muscle.

Authors:  Rüdiger Rudolf; Muzamil M Khan; Danilo Lustrino; Siegfried Labeit; Isis C Kettelhut; Luiz C C Navegantes
Journal:  Front Physiol       Date:  2013-10-17       Impact factor: 4.566

7.  STK25 inhibits PKA signaling by phosphorylating PRKAR1A.

Authors:  Xiaokan Zhang; Bryan Z Wang; Michael Kim; Trevor R Nash; Bohao Liu; Jenny Rao; Roberta Lock; Manuel Tamargo; Rajesh Kumar Soni; John Belov; Eric Li; Gordana Vunjak-Novakovic; Barry Fine
Journal:  Cell Rep       Date:  2022-08-16       Impact factor: 9.995

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.